A PHASE-I DOSE-ESCALATING TRIAL OF LY335979, A POTENT MULTIDRUG-RESISTANCE MODULATOR, COMBINED WITH DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANCIES

Authors
RUBIN E ZAMEK R MEDINA M TOPPMEYER D BUBEN J PRIEST T JORDAN C SLAPAK C
Citation
E. Rubin et al., A PHASE-I DOSE-ESCALATING TRIAL OF LY335979, A POTENT MULTIDRUG-RESISTANCE MODULATOR, COMBINED WITH DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Annals of oncology, 9, 1998, pp. 553-553
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
553 - 553
Database
ISI
SICI code
0923-7534(1998)9:<553:APDTOL>2.0.ZU;2-A